loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Wuxi Taxus Pharmaceutical

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 Allopurinol (1)

02 L5-Methyltetrahydrofolate Calcium (1)

03 Paclitaxel (1)

filter

01 Wuxi Taxus Pharmaceutical (3)

filter

01 China (3)

URL Supplier Web Content
The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw m...
The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw materials and preparations. At present, the industrial chain of yew resource cultivation, yew branch and leaf processing, paclitaxel raw material preliminary product, paclitaxel injection and other anti-tumor drug preparations has been formed.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw m...
The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw materials and preparations. At present, the industrial chain of yew resource cultivation, yew branch and leaf processing, paclitaxel raw material preliminary product, paclitaxel injection and other anti-tumor drug preparations has been formed.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw m...
The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw materials and preparations. At present, the industrial chain of yew resource cultivation, yew branch and leaf processing, paclitaxel raw material preliminary product, paclitaxel injection and other anti-tumor drug preparations has been formed.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY